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HYPERTENSION
Age-specificity of blood-pressure-
associated complications
Jan A. Staessen
In an analysis of electronic health records, 1.25 million patients aged 
≥30 years without diagnosed cardiovascular disease experienced 83,098 
cardiovascular events during follow-up (median 5.2 years). Associations 
between incident cardiovascular disease and blood pressure differed for 
systolic and diastolic blood pressures and between the 12 cardiovascular 
end points examined.
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The concept that the risk associated with 
elevated systolic and diastolic blood pres-
sure is age-specific and not concordant for 
all cardiovascular complications is not new, 
but has never before been highlighted on the 
scale of a new analysis by Rapsomaniki et al.1 
Compared with diastolic blood pressure, high 
systolic blood pressure had a greater effect on 
angina, myocardial infarction, and peripheral 
artery disease, whereas raised diastolic blood 
pressure had a greater effect on abdominal 
aortic aneurysm.1 The Framingham investi-
gators2,3 and others4 showed as early as 19712 
that diastolic blood pressure was the strongest 
predictor of cardiovascular outcome in indi-
viduals aged <50 years, with an increasing 
importance of systolic blood pressure with 
older age. In 2001, Franklin et al. observed 
that with increasing age, predictors of coro-
nary heart disease gradually shifted from 
diastolic to systolic blood pressure and then 
to pulse pressure.3 Diastolic blood pressure 
was the strongest predictor of coronary heart 
disease in individuals aged <50 years.3 In 
those aged 50–59 years, a transition occurred, 
during which all three blood-pressure indi-
ces were similarly accurate predictors, but 
in those aged ≥60 years, diastolic blood 
pres sure was negatively associated with the 
risk of coronary heart disease, so that pulse 
pressure became a superior predictor to sys-
tolic blood pressure.3 These epidemio logical 
observations contradicted the long-held 
view, which guided the design of the first 
 antihypertensive-drug trials, that diastolic 
blood pressure might be the best predictor of 
risk, being a measure of the resistance that the 
heart must overcome to eject blood.
Major limitations of the study by 
Rapsomaniki et al.1 are that the analysis is 
entirely based on office blood pressure, 
which is no longer the state-of-the-art 
method to measure blood pressure or diag-
nose and manage hypertension;5 includes no 
information about the quality of the office 
blood-pressure measurements across 225 
primary care practices; and that informa-
tion on the technique of blood-pressure 
measurement is also lacking.1 The auscul-
tatory approach can be used to measure sys-
tolic and diastolic blood pressure, whereas 
automated oscillometric devices extrapolate 
systolic and diastolic blood pressure from 
the measurement of mean arterial pres-
sure. Digit and number preference provide 
information on the quality of auscultatory 
blood-pressure readings.6 Diastolic and 
mean arterial pressures are similar through-
out the arterial bed, whereas systolic blood 
pressure and pulse pressure are subject to 
systolic augmentation when the forward and 
reflected pressure waves collide in the central 
elastic arteries, a phenomenon that substan-
tially increases with ageing.6 Central systolic 
augmentation is a risk factor for stroke and 
myocardial infarction. To what extent the 
technique of office blood-pressure measure-
ment and systolic augmentation6 influenced 
findings is unknown.
Another major limitation is that lifetime 
risks were estimated by extrapolation of 
event rates recorded in individuals enter-
ing the cohort at different ages, rather than 
by following up each individual over his or 
her lifetime. On its own, this design aspect 
explains at least part of the heterogeneity 
with age in the associations between sys-
tolic and diastolic blood pressure and the 12 
cardiovascular end points studied. Indeed, 
death of participants from stroke or myo-
cardial infarction in middle age biases the 
analyses to the discovery of associations with 
other complications during older age. The 
difference in lifetime risk between individu-
als who were normotensive and those who 
were hypertensive at the index age of 30 years 
ranged from 0.1% for abdominal aortic aneu-
rysm to 4.0% for stable angina.1 The corre-
sponding number of life-years lost ranged 
from 0.04 to 1.11 years, respectively. The 
risk differences were not adjusted, whereas 
the numbers of life-years lost were adjusted 
for sex, tobacco smoking, diabetes mellitus, 
and levels of total and HDL cholesterol.1 The 
effect of differences in BMI between indi-
viduals who were normotensive and those 
who were hypertensive on the reported esti-
mates is uncertain. In addition, adjustment 
for total-cholesterol and HDL-cholesterol 
levels is questionable, because these vari-
ables were not measured in 80% and 84% 
of the individuals, respectively.1 The same 
uncertain ty applies to the sensitivity analy-
sis that included 679,354 individuals with 
unknown blood pressure at baseline.
The observed heterogeneity in the associa-
tion between cardiovascular complications 
and systolic and diastolic blood pressures 
needs to be confirmed using out-of-office 
blood-pressure measurement.1 We inves-
tigated the risk associated with systolic 
and diastolic blood pressure, using 24-h 
ambulatory monitoring as the state-of-the-
art approach in 8,341 untreated individu-
als (mean age 50.8 years; 46.6% women; 
Table 1).7 Isolated diastolic hypertension 
(pressure ≥80 mmHg) did not increase the 
risk of all-cause mortality, cardiovascular 
mortality, or stroke, but was associated with 
an increased risk of fatal or nonfatal cardio-
vascular, cardiac, or coronary events.7 Isolated 
systolic hypertension (pressure ≥130 mmHg) 
and mixed diastolic plus systolic hypertension 
were associated with increased risks of all the 
aforementioned end points.7 In individuals 
aged <50 years, 24-h diastolic blood pressure 
was the main driver of risk, reaching signifi-
cance for total and cardiovascular mortality, 
and for all cardiovascular end points when 
combined with a nonsignificant contribution 
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of the 24-h systolic blood pressure.7 In indi-
viduals aged >50 years, the 24-h systolic 
blood pressure predicted all end points, with 
a nonsignificant contribution of the 24-h 
diastolic blood pressure.7 The interactions 
between age and the 24-h systolic and dias-
tolic blood pressures reached significance for 
all cardiovascular and coronary events.7
Investigators in the Global Burden of 
Disease Study 20108 reported that high 
blood pressure is the leading risk factor for 
the global disease burden, and is estimated 
to cause 9.4 million deaths every year—more 
than half of the estimated 17 million deaths 
per year caused by cardiovascular disease. 
Rapsomaniki et al. emphasize the unmet 
need of improved implementation of exist-
ing blood-pressure-lowering strategies and 
management of other cardiovascular risk 
factors.1 The suggestion from Peter Sever9 
to abandon diastolic pressure measurement 
and rely only on systolic pressure measure-
ment for the management of hypertension 
is certainly not an option. Increasing aware-
ness and education of patients and caregivers 
is probably the most-important step to take. 
In the study by Rapsomaniki et al., only 80% 
of the 545,816 patients with hypertension 
had a systolic pressure <140 mmHg and a 
diastolic pressure <90 mmHg, and only 49% 
of these patients were treated.1 The percent-
age of treated patients with controlled blood 
pressure was not reported. The situation in 
the UK is similar to that in other parts of 
the world. According to statistics generated 
by the International Collaborative Study of 
Cardiovascular Disease in Asia10 performed 
in 2000–2001, 27.2% of the adult Chinese 
population aged 35–74 years had hyper-
tension according to conventional blood-
pressur e measurement (totalling 129,824,000 
patients). Among these individuals with 
hypertension, only 44.7% were aware of 
their high blood pressure, 28.2% were taking 
antihypertensive medication, and 8.1% of 
patients achieved blood-pressure control.10
In conclusion, the main message from the 
high-powered study by Rapsomaniki et al.,1 
and numerous other reports,2–4,7 is that both 
systolic and diastolic pressures confer risk, 
and that their role as risk indicators changes 
with age. In our effort to curb the epidemic 
of noncommunicable diseases,8 we must raise 
the pressure on hypertension, with the goal of 
extending life with disease-free years.
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Table 1 | Multivariable-adjusted standardized hazard ratios for 24-h systolic and diastolic blood pressures by age group7
End point Adjustment Age <50 years (n = 3,761) Age ≥50 years (n = 4,580)
Number 
of events
Diastolic pressure
HR (95% CI)
Systolic pressure
HR (95% CI)
Number 
of events
Diastolic pressure
HR (95% CI)
Systolic pressure
HR (95% CI)
Mortality
All-cause A
FA
64 1.38 (1.08–1.77)*
2.05 (1.26–3.33)*
1.20 (0.86–1.66)
0.56 (0.30–1.05)
863 1.17 (1.10–1.25)‡
1.03 (0.94–1.13)
1.21 (1.14–1.29)‡
1.19 (1.08–1.30)‡
Cardiovascular A
FA
16 2.34 (1.61–3.39)‡
4.07 (1.60–10.40)*
2.23 (1.32–3.78)*
0.44 (0.13–1.56)
340 1.31 (1.18–1.44)‡
0.96 (0.85–1.10)
1.47 (1.35–1.61)‡
1.51 (1.34–1.70)‡
Noncardiovascular A
FA
46 1.13 (0.83–1.55)
1.73 (0.96–3.12)
0.93 (0.61–1.42)
0.53 (0.25–1.13)
502 1.06 (0.97–1.16)
1.09 (0.95–1.25)
1.03 (0.94–1.12)
0.96 (0.84–1.10)
Fatal and nonfatal events
All cardiovascular A
FA
47 1.65 (1.27–2.14)‡
1.74 (1.03–2.93)§
1.68 (1.19–2.36)*
0.92 (0.47–1.81)
697 1.36 (1.27–1.46)‡
1.06 (0.97–1.17)
1.44 (1.35–1.53)‡
1.39 (1.27–1.51)‡
Cardiac A
FA
37 1.53 (1.12–2.08)*
1.67 (0.92–3.03)
1.67 (1.07–2.62)§
0.88 (0.40–1.90)
440 1.25 (1.13–1.38)‡
1.01 (0.90–1.14)
1.37 (1.26–1.48)‡
1.36 (1.22–1.52)‡
Coronary A
FA
28 1.63 (1.16–2.30)*
1.73 (0.87–3.45)
1.67 (1.07–2.62)§
0.92 (0.37–2.24)
320 1.25 (1.13–1.38)‡
1.01 (0.88–1.15)
1.35 (1.23–1.48)‡
1.35 (1.18–1.53)‡
Stroke A
FA
7 2.31 (1.25–4.27)*
2.24 (0.62–8.20)
2.43 (1.12–5.26)§
1.04 (0.21–5.26)
249 1.61 (1.43–1.81)‡
1.14 (0.97–1.34)
1.65 (1.49–1.83)‡
1.52 (1.32–1.76)‡
The cause of death was unknown in 23 patients. Hazard ratios express the risk associated with an increase by one standard deviation in 24-h systolic (13.5 mmHg) or diastolic (8.2 mmHg) blood 
pressure. All models were adjusted for cohort, sex, age, BMI, tobacco smoking, alcohol consumption, serum cholesterol, and history of cardiovascular disease and diabetes mellitus. Adjusted 
models (A) include either systolic or diastolic blood pressure, whereas fully adjusted models (FA) include both systolic and diastolic blood pressures in addition to the aforementioned covariables. 
Significance of the hazard ratios: *P ≤0.01, ‡P ≤0.001, §P ≤0.05. The interaction between blood pressure and age (continuous) in fully adjusted models was significant or borderline significant for 
cardiovascular mortality (0.036 ≤ P ≤ 0.058), all cardiovascular events (0.0037 ≤P ≤ 0.0048), and coronary events (0.012 ≤P ≤ 0.043). Reprinted from Li, Y. et al. Ambulatory hypertension subtypes 
and 24-hour systolic and diastolic blood pressure as distinct outcome predictors in 8341 untreated people recruited from 12 populations. Circulation doi:10.1161/CIRCULATIONAHA.113.004876.
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